Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2022-09-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
中国证监会关于同意公司首次公开发行股票注册的批复
Capital/Financing Update Classification · 95% confidence The document is an official approval from the China Securities Regulatory Commission (CSRC) regarding the registration of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd.'s initial public offering (IPO) of shares. It references regulatory laws and the registration process for the IPO. The document is short (612 characters) and is a formal approval notice rather than a detailed financial report or prospectus. It does not contain financial statements or detailed financial data but is an official regulatory approval related to capital raising. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-09-15 Chinese
东兴证券股份有限公司关于公司首次公开发行股票并在创业板上市之发行保荐书
Regulatory Filings Classification · 95% confidence The document is titled as an "发行保荐书" which translates to "Sponsorship Letter for Issuance" related to the initial public offering (IPO) and listing of Shenzhen Mehow Innovative Medical Technology Co., Ltd. on the ChiNext board. It contains detailed information about the underwriting and sponsorship process, the legal and regulatory compliance, due diligence, internal review procedures, and the recommendation for the IPO. The document is a formal sponsorship letter issued by the underwriting institution (Dongxing Securities) to support the company's IPO application. This type of document is typically part of the IPO process filings and is not an annual report, earnings release, or other financial report. It is a regulatory filing related to the IPO process and securities issuance. Given the detailed nature and regulatory context, this document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. The document is not a report publication announcement since it is the actual sponsorship letter, not just an announcement of a report. It is not a proxy solicitation, dividend notice, or capital change announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-09-15 Chinese
东兴证券股份有限公司关于公司首次公开发行股票并在创业板上市之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to "Listing Sponsorship Letter" or "Sponsorship Document" for the initial public offering (IPO) and listing on the Growth Enterprise Market (创业板) of Shenzhen Stock Exchange. It contains detailed company information, business description, core technologies, R&D activities, financial data, risk factors, and compliance statements. The document is clearly related to the IPO process and the underwriting/sponsorship of the stock issuance. It is not a typical annual report, earnings release, or other routine financial report. Instead, it is a formal sponsorship document required by regulatory authorities in China for the IPO process. This type of document is best classified under Capital/Financing Update (CAP) because it relates to the company's initial public offering and stock issuance activities, which are financing events. The document is lengthy (15,000 characters) and contains substantive information, not just an announcement or a brief summary, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the most appropriate classification is CAP with high confidence.
2022-09-15 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.